MSA Cartridge Review

Is the MSA 815184 GMI the right iodine-vapor cartridge for nuclear medicine and reactor maintenance?

Short answer: Yes — if your exposure profile includes elemental iodine (I₂) or methyl iodide (CH₃I) in a nuclear medicine, radiopharmacy, or nuclear power plant maintenance environment, the MSA GMI is the Comfo-platform solution with an integrated P100 stage for simultaneous particulate protection. It is purpose-engineered for radioiodine respiratory protection and has no direct cross-brand equivalent in its specific iodine-plus-P100 formulation. Snap-on Advantage platform users should evaluate the MSA Advantage GMI instead.

Published to MSA respirator filters and cartridges · /blogs/product-reviews/msa-815184-gmi-iodine-p100-cartridge-review

The MSA 815184 GMI occupies a specialized niche that very few cartridges on the market address: combined elemental iodine vapor (I₂) and methyl iodide (CH₃I) protection with an integrated P100 particulate stage, on the MSA Comfo bayonet platform. Nuclear medicine technologists, radiopharmacists, and nuclear power plant maintenance crews are the primary users — a population that requires documented NIOSH-approved respiratory protection for radioiodine exposure, not general industrial gas cartridges.

This review covers the GMI's protection chemistry, platform compatibility, application boundaries, and how it fits against its closest site alternatives — the Advantage GMI for snap-on users, and the MSA MERSORB for the mercury/chlorine market that sometimes appears in the same facility. One important clinical framing note: the GMI prevents respiratory uptake of radioiodine — it does not replace potassium iodide (KI) thyroid-blocking tablets, which address thyroid dose from residual body burden via a different mechanism entirely.

Who the MSA 815184 GMI is for

• Nuclear medicine technologists — handling I-131 in therapy dose preparation, diagnostic imaging, and laboratory processing
• Radiopharmacists — compounding or dispensing radioiodine-labeled pharmaceuticals in nuclear pharmacy settings
• Nuclear power plant maintenance crews — reactor coolant system work and fuel handling where elemental iodine release is a credible exposure scenario
• Nuclear medicine preparation labs — research facilities synthesizing radioiodinated tracers or antibodies
• Thyroid cancer treatment facilities — clinical staff involved in high-dose I-131 administration and patient handling during treatment isolation
• Any industrial hygiene program that has documented airborne radioiodine exposure potential and specifies an iodine-specific NIOSH-approved cartridge

For Advantage snap-on platform users in the same environments, the MSA Advantage GMI provides equivalent iodine + P100 coverage on the snap-on mount. Browse the full MSA respirator filters and cartridges collection to compare platform options.

What the MSA GMI does well

Dual iodine chemistry — I₂ and CH₃I in one cartridge

Radioiodine exposure in nuclear environments occurs in two primary chemical forms: elemental iodine (I₂), a volatile solid that sublimates at room temperature, and methyl iodide (CH₃I), an organic iodide produced during fission and used as a tracer compound. These two forms have different physical and chemical properties — I₂ is relatively large and polar; CH₃I is small and less polar — requiring a sorbent formulation that captures both. The GMI's impregnated activated carbon bed addresses both forms in a single cartridge, eliminating the need for stacking separate I₂ and CH₃I cartridges in mixed-exposure environments.

Integrated P100 stage — no separate filter required

The GMI combines the iodine sorbent bed with a NIOSH-rated P100 particulate filter (≥99.97% efficiency) in one assembly. This matters practically: nuclear medicine and reactor environments often generate both aerosols (radioactive particles from liquid spills, aerosol generators, or contaminated surfaces) and vapor-phase iodine simultaneously. A gas-only cartridge without P100 would require a separate stacked filter, adding bulk, breathing resistance, and a second change-out schedule to track. The integrated design simplifies the program and the maintenance burden. Compare this to the MSA GME, which has no particulate stage, or the MSA GMT, which also requires a separate P100 filter stacked over it for combined protection.

Primary use case for the Ultra-Elite at APF 50

The GMI is predominantly deployed with the MSA Ultra-Elite full-face respirator, which delivers APF 50. In nuclear medicine facilities, airborne I-131 concentrations during therapy dose preparation or patient handling can be multiples of the derived air concentration (DAC) limit, requiring the full APF 50 protection factor. Half-mask Comfo facepieces (APF 10) may be adequate for lower-exposure monitoring tasks, but high-activity handling typically requires full-face protection. The program's RSO and CIH define the required APF based on measured or modeled air concentrations for each task.

No direct cross-brand equivalent on the Comfo mount

This is a genuine market gap, not a marketing claim. The 3M and Moldex product lines do not offer an iodine-specific vapor cartridge with integrated P100 on the Comfo bayonet platform. Cross-brand mixing (3M cartridge on MSA facepiece or vice versa) is prohibited under the NIOSH approval framework — a NIOSH approval is granted to a specific facepiece/cartridge combination, not to the cartridge alone. Facilities using MSA Comfo facepieces for their nuclear medicine respiratory protection program have the GMI as their only NIOSH-approved iodine option on that platform.

NIOSH 42 CFR Part 84 approval

The GMI carries NIOSH approval under 42 CFR Part 84, independently verifiable on the NIOSH Certified Equipment List (CEL). For NRC-regulated facilities (nuclear power plants, nuclear pharmacies), NIOSH-approved respiratory protection equipment is a regulatory baseline requirement under 10 CFR Part 20 (radiation protection) as well as OSHA 29 CFR 1910.134. Unapproved or non-NIOSH-tested cartridges do not satisfy either standard.

Where the MSA GMI falls short

Does not protect against acid gases, inorganic gases, or organic vapors

The GMI's sorbent bed is formulated specifically for iodine compounds. It provides no protection against the broad inorganic gas matrix covered by the GME (Cl₂, HF, SO₂, H₂S, NH₃, etc.), the acid gases covered by the GMB, or organic vapors covered by the GMA. Nuclear facilities with co-existing chemical hazards — maintenance work in areas where acid cleaning or organic solvent use occurs simultaneously with radioiodine potential — require a separate cartridge selection process. A single GMI does not cover mixed chemical + radioiodine scenarios.

No ESLI — change-out schedule is mandatory

The MSA GMI has no end-of-service-life indicator. Iodine breakthrough at low concentrations may not be detectable by odor at harmful concentrations — particularly for I-131, where the radiological hazard (absorbed dose to the thyroid) is the concern rather than acute chemical toxicity. Relying on smell or taste as breakthrough indicators is not a compliant change-out strategy under OSHA 29 CFR 1910.134. The written respirator program must specify an objective change-out schedule based on measured air concentrations and manufacturer service-life data.

Does not replace potassium iodide (KI) thyroid blocking

This is the most important clinical boundary to state accurately. The GMI prevents inhalation exposure to radioiodine — it reduces the dose delivered to the thyroid via the respiratory route. It does not address thyroid dose from radioiodine already absorbed into the body, radioiodine ingested through contaminated food or water, or dose from external photon irradiation. Potassium iodide (KI) saturates the thyroid to block uptake of radioiodine regardless of the entry route — it operates via a completely different mechanism. In a nuclear emergency or high-activity spill scenario, both GMI respirator protection and KI administration may be indicated; they are complementary, not interchangeable. The facility's radiation safety officer (RSO) and emergency response plan govern KI distribution protocols.

Comfo bayonet only — Advantage users need a different SKU

The GMI uses the Comfo GM-series bayonet mount. It is physically incompatible with the snap-on mount of the MSA Advantage 200, 290, 420, 1000, and 3000 series — the most widely used MSA half-mask in non-nuclear industrial settings. Facilities running mixed fleets (Comfo for full-face nuclear work, Advantage for routine maintenance half-mask use) must stock both GMI (Comfo bayonet) and Advantage GMI (snap-on) to cover both facepiece types.

MSA GMI vs. the competitive set

3M does not offer a direct iodine-specific (I₂ + CH₃I) vapor cartridge with P100 on the Comfo bayonet platform. Facilities locked to MSA Comfo facepieces have the GMI as their only NIOSH-approved iodine cartridge option for that mount. Cross-brand mixing is not permitted under the NIOSH approval framework.

MSA Advantage GMI on Amazon MSA MERSORB on Amazon

Comfo specialty cartridge family comparison

• Buy the GMI (815184) if elemental iodine (I₂) or methyl iodide (CH₃I) is the primary vapor-phase exposure — nuclear medicine, nuclear pharmacy, reactor iodine work — with an integrated P100 stage.
• Buy the MERSORB (815185) if elemental mercury vapor (Hg⁰) or chlorine is the documented hazard — chlor-alkali, dental, mercury recovery, fluorescent lamp recycling. See the MERSORB review.
• Buy the Low-Profile P100 (815177) if particulate-only protection is needed — stacks over gas cartridges when separate gas and particulate coverage are both required. See the P100 filter review.

Shop the Comfo specialty series on Amazon → MSA GMI MSA MERSORB MSA P100 Filter

Compatible respirators for the MSA GMI

The MSA 815184 GMI uses the GM-series bayonet mount. The GMI is primarily deployed with full-face facepieces in nuclear medicine and power plant environments where APF 50 is required. Compatible facepieces:

• MSA Ultra-Elite (full-face) — the primary pairing for nuclear medicine and reactor maintenance; APF 50; silicone full-face seal; widely used in NRC-regulated facilities
• MSA Ultra-Twin (full-face) — dual-cartridge full-face; APF 50; older design still in active fleet use
• MSA Comfo Classic (half-mask) — APF 10; appropriate only for lower-exposure monitoring tasks where the program documents APF 10 as sufficient
• MSA Comfo II (half-mask) — APF 10; same APF note
• MSA Advantage 200 LS (half-mask) — APF 10; Comfo bayonet variant of the Advantage 200 series

Not compatible: MSA Advantage 200, 290, 420, 1000, 3000 (snap-on mount); any 3M or Moldex facepiece. For Advantage snap-on platform users requiring iodine protection, use the MSA Advantage GMI (815641) instead — reviewed separately at MSA 815641 Advantage GMI review.

Top compatible respirators on Amazon → MSA Ultra-Elite MSA Advantage 200 LS

Where the GMI fits in the nuclear respiratory protection market

Radioiodine respiratory protection sits at the intersection of industrial hygiene, radiation protection, and pharmaceutical safety. The regulatory framework governing GMI use spans OSHA 29 CFR 1910.134 (respiratory protection program), NRC 10 CFR Part 20 (radiation protection), and — for nuclear medicine facilities — state radiation control program regulations. Understanding where the cartridge fits in this multi-regulatory context is essential for program compliance.

The Comfo specialty cartridge line covers three distinct high-hazard niches: radioiodine (GMI), mercury vapor and chlorine (MERSORB), and tritium/inorganic multi-gas (GMT — reviewed at MSA GMT review). Nuclear power plants may use all three cartridge types in different zones or during different maintenance activities — the GMI in radioiodine monitoring areas, the GMT in tritium-handling areas, and the MERSORB if mercury instrumentation or chlorine disinfection systems are present in the same facility. A well-structured respiratory protection program identifies each zone's hazard matrix and specifies the correct cartridge for each task, rather than defaulting to one cartridge type across all nuclear work.

For the broader inorganic-gas and particulate protection needs that accompany nuclear work outside specific radioiodine zones, the GME-P100 covers nine inorganic gases with integrated P100 — without the iodine sorbent, at a lower per-cartridge cost.

Total cost of ownership

The MSA 815184 GMI sells in a box of 6 at $185.56, making each cartridge $30.93. Key program cost drivers:

• Per-cartridge cost: $30.93
• Standard box quantity: 6 cartridges ($185.56/box)
• Per-pair cost (one shift, two cartridges): $61.86
• Annual cost per worker at end-of-shift change-out (250 days): ~$15,465 — conservative worst-case scenario; actual consumption depends on the IH-documented change-out schedule
• Compatible facepiece investment: The MSA Ultra-Elite is the primary full-face pairing; amortized over its service life, the facepiece cost is secondary to consumable cartridge cost in high-frequency programs

For comparison, the Advantage snap-on platform alternative — the MSA Advantage GMI (815641) — should be evaluated for facilities considering a platform transition; per-cartridge economics for that SKU may differ. The decision between Comfo bayonet and Advantage snap-on is driven primarily by facepiece selection (full-face APF 50 need vs. half-mask APF 10 sufficiency) rather than cartridge cost alone.

Final verdict

The MSA 815184 GMI earns 4.6/5 for being the only NIOSH-approved iodine-specific vapor cartridge with integrated P100 on the MSA Comfo bayonet platform — a genuine market gap that makes it the mandatory specification for nuclear medicine and radioiodine-handling programs running Comfo facepieces. The half-point deduction reflects the absence of an ESLI and the narrow application scope — this is the right cartridge for a specific problem, not a versatile multi-hazard solution.

• Buy the GMI (815184) if your written respirator program covers radioiodine (I₂, CH₃I) exposure on the Comfo bayonet platform — nuclear medicine, nuclear pharmacy, reactor iodine work.
• Buy the Advantage GMI (815641) if your facepiece is the MSA Advantage snap-on series.
• Buy the MERSORB (815185) if mercury vapor or chlorine — not iodine — is the documented hazard. See the MERSORB review.
• Buy the GMT (806059) if tritium and nine-gas inorganic coverage is required — not iodine. See the GMT review.

VIEW ON WC SAFETY → CHECK PRICE ON AMAZON →

MSA 815184 GMI Cartridge — Frequently Asked Questions

What does the MSA 815184 GMI cartridge protect against?

The MSA GMI protects against elemental iodine vapor (I₂), methyl iodide (CH₃I), and airborne particulates at P100 efficiency (≥99.97%). It does not protect against acid gases, organic vapors, inorganic multi-gas hazards (Cl₂, SO₂, HF, H₂S), mercury vapor, tritium, carbon monoxide, or oxygen-deficient atmospheres. Its application is specifically nuclear medicine, radiopharmacy, and nuclear power plant radioiodine environments.

MSA GMI vs. MSA Advantage GMI — which one do I need?

The choice is determined entirely by your facepiece platform. The MSA 815184 GMI uses the Comfo GM-series bayonet mount — compatible with Comfo Classic, Comfo II, Advantage 200 LS, Ultra-Twin, and Ultra-Elite. The MSA Advantage GMI (815641) uses the snap-on mount for Advantage 200, 290, 420, 1000, and 3000 series. The iodine protection chemistry is equivalent; the mount is not interchangeable. Check your facepiece model before ordering.

Does the MSA GMI protect against radioactive iodine (I-131)?

The GMI captures the chemical forms of iodine it is rated for — elemental iodine (I₂) and methyl iodide (CH₃I) — including their radioactive isotope variants (I-131 in those chemical forms). It prevents the inhalation route of radioiodine exposure. It does not block external gamma/beta radiation from I-131, and it does not replace thyroid-blocking potassium iodide (KI) for preventing thyroid uptake from iodine already absorbed systemically. Consult your facility's RSO for a complete radioiodine protection plan that addresses all exposure pathways.

Does the GMI replace potassium iodide (KI) thyroid protection?

No. The GMI and KI address different exposure mechanisms and are complementary, not interchangeable. The GMI prevents inhalation uptake of radioiodine through the respiratory tract. KI saturates the thyroid to block uptake of radioiodine regardless of entry route — ingestion, inhalation of residual body burden, or skin absorption. In a high-activity spill scenario or emergency involving radioiodine release, both a respirator with GMI cartridges and KI administration may be indicated. KI distribution is governed by the facility's RSO and emergency response plan, not the respiratory protection program alone.

Is the MSA GMI NIOSH approved?

Yes. The MSA 815184 GMI is approved under NIOSH 42 CFR Part 84. Verify the approval independently on the NIOSH Certified Equipment List (CEL). For NRC-regulated nuclear medicine and nuclear power facilities, NIOSH-approved respiratory protection is a regulatory baseline under both 10 CFR Part 20 and OSHA 29 CFR 1910.134. Non-NIOSH-approved iodine cartridges do not satisfy program requirements.

What facepieces are compatible with the MSA 815184 GMI?

The GMI uses the Comfo GM-series bayonet mount and is compatible with MSA Comfo Classic, Comfo II, Advantage 200 LS, Ultra-Twin, and Ultra-Elite. It is not compatible with MSA Advantage snap-on facepieces (200, 290, 420, 1000, 3000) or any 3M or Moldex facepiece.

What protection factor does the GMI system provide?

The assigned protection factor (APF) is determined by the facepiece, not the cartridge. The MSA Ultra-Elite and Ultra-Twin full-face facepieces paired with the GMI deliver APF 50 — allowing use at up to 50x the applicable TLV or PEL. Half-mask Comfo facepieces (Comfo Classic, Comfo II, Advantage 200 LS) deliver APF 10. For nuclear medicine dose preparation and high-activity reactor tasks, APF 50 is typically the minimum required; the written program's CIH and RSO define the required APF by task and measured concentration.

Does the MSA GMI have an end-of-service-life indicator (ESLI)?

No. The GMI has no ESLI. Iodine compounds — especially at the low concentrations encountered in nuclear medicine preparation — may not provide reliable odor warning before breakthrough. OSHA 29 CFR 1910.134 Appendix B requires a documented change-out schedule based on objective data when no ESLI is present. Consult the MSA Technical Data Sheet and your CIH or RSO to develop a compliant schedule for your specific air concentration data.

MSA GMI vs. MSA MERSORB — what is the difference?

The MERSORB (815185) uses MERSORB sorbent technology designed specifically for elemental mercury vapor (Hg⁰) and chlorine (Cl₂) — it is the correct choice for chlor-alkali workers, dental professionals, and mercury recovery operations. The GMI is designed for iodine vapor (I₂ and CH₃I). They address entirely different chemical hazards, and one cannot substitute for the other. See the MERSORB review for the full mercury vapor program analysis.

Can I use the GMI for general hospital or pharmacy environments without a nuclear medicine program?

The GMI is not a general-purpose hospital or pharmacy cartridge — it is engineered for iodine vapor specifically. Standard hospital and compounding pharmacy environments typically involve different vapor hazards (formaldehyde, glutaraldehyde, isoflurane, organic solvents) better addressed by OV or OV/acid gas cartridges. Unless your facility's IH assessment documents airborne I₂ or CH₃I as a credible exposure — which typically means an active nuclear medicine or radiopharmacy program — a different cartridge is the appropriate specification.

What is the per-cartridge cost for the MSA 815184 GMI?

The MSA 815184 GMI sells in a standard box of 6 cartridges at $185.56, making the per-cartridge cost $30.93. This is competitive for a specialty nuclear-grade iodine cartridge with integrated P100 filtration. For comparison, the MERSORB (mercury/chlorine/P100) is $53.83 per cartridge, while the Low-Profile P100 filter (particulate only) is $7.85 per filter. Check current Amazon pricing.

Is there a 3M equivalent to the MSA GMI?

3M does not offer a direct equivalent to the MSA GMI in an iodine-specific (I₂ + CH₃I) vapor cartridge with integrated P100 on the Comfo bayonet mount. Even if a cross-brand iodine cartridge existed, cross-brand mixing — using a 3M cartridge on an MSA facepiece or vice versa — is not permitted under the NIOSH approval framework, which approves the facepiece/cartridge combination as a system. Facilities using MSA Comfo facepieces have the GMI as their only NIOSH-approved iodine cartridge option on that platform.

How many cartridges come in a box of MSA 815184 GMI?

The standard packaging for the MSA 815184 GMI is a box of 6 cartridges ($185.56 per box, $30.93 per cartridge). Note that respiratory cartridges are used in pairs — one on each side of a full-face or dual-cartridge half-mask facepiece — so a box of 6 provides 3 complete cartridge pairs (3 shifts at end-of-shift change-out for a single user).

Can the GMI be stacked with additional filters?

The GMI already includes an integrated P100 particulate stage, so additional P100 stacking is not necessary or recommended unless specifically directed by the manufacturer's instructions. In environments requiring supplemental protection beyond the GMI's iodine + P100 coverage — such as concurrent acid gas hazards — consult the MSA Technical Data Sheet and your CIH for a cartridge combination strategy, as the GMI's integrated design may limit stacking options compared to a bare gas cartridge like the GME.

Does the MSA GMI protect against both elemental iodine and methyl iodide?

Yes. The GMI's sorbent formulation is specifically designed to capture both elemental iodine (I₂), a volatile solid that sublimates at room temperature, and methyl iodide (CH₃I), an organic iodide with distinct chemical properties from I₂. This dual-form coverage is critical in reactor and nuclear medicine environments where both forms may be present. A cartridge rated for I₂ alone would have inadequate protection against CH₃I in mixed-iodine environments.

What is the MSA GMI's Assigned Protection Factor for full-face use?

When used with the MSA Ultra-Elite full-face respirator, the GMI system achieves APF 50 under OSHA's respiratory protection standard (29 CFR 1910.134 Table 1). This means the combination can be used at iodine concentrations up to 50 times the applicable occupational exposure limit, subject to the written respirator program's documentation of that protection level. For tasks at or below 10x the OEL, a half-mask Comfo facepiece with the GMI provides APF 10, which is adequate for lower-exposure monitoring or incidental contact scenarios.